Skip to content
Recall Observatory FDA recall evidence

Drug product

Loxapine Capsules, USP 25 mg, Rx Only, 100-count bottles, NDC 0378-7025-01

D-0824-2018

April 24, 2018

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 79955
Status
Terminated
Classification
Class II
Quantity
8,679 bottles
Official record key
drug-enforcement:D-0824-2018

Official wording

Reason: CGMP Deviations

Code information: NDC # 0378-7025-01 Lot Numbers: 3083756, Exp. 3/31/19 3083757, Exp. 3/31/19 3083758, Exp. 3/31/19 3083759, Exp. 3/31/19 3083760, Exp. 3/31/19 3083761, Exp. 3/31/19

Distribution pattern: Product was distributed throughout the United States, including Puerto Rico.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations